Results 21 to 30 of about 17,527,148 (207)

Area under Curve (AUC) comparison.

open access: yes, 2013
Area under Curve (AUC) comparison measuring the ability of recovering the original PPI networks: (a) Y_Tong, (b) H_Bind, (c) H_InAct, (d) F_BioGrid, (e) H_BioGrid using embedding space dimensions of 1 to 20.
Lin Zhu (192179)   +3 more
core   +1 more source

Synthetic single‐domain antibodies as immunoconjugate therapeutics

open access: yesFEBS Letters, EarlyView.
Single‐domain antibodies (sdAbs), at about one‐tenth the size of conventional antibodies, overcome the traditional barrier of deeper penetration into tumors. Their small footprint and ease of engineering facilitate transport of cytotoxic payloads or radionuclides directly to cancer cells.
Robbins Puthenveetil   +8 more
wiley   +1 more source

Prediction performance (area under curve, AUC) of integrative models.

open access: yes, 2016
Prediction performance (area under curve, AUC) of integrative models.
Matthew C. Cowperthwaite (93322)   +3 more
core   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

Area Under the curve (AUC) of different OCT measurements.

open access: yes, 2019
Area Under the curve (AUC) of different OCT measurements.
Alfonso Casado (697004)   +8 more
core   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

Area Under the Curve (AUC) values after MaxEnt.

open access: yes, 2014
Area Under the Curve (AUC) values after MaxEnt.
Victor Sanchez-Cordero (5659030)   +5 more
core   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

open access: yesMolecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang   +9 more
wiley   +1 more source

Area under receiver operating characteristics curve (AUC) for D-dimer, H3Cit-DNA and NE.

open access: yes, 2022
Area under receiver operating characteristics curve (AUC) for D-dimer, H3Cit-DNA and NE.
Philip Smith (188930)   +7 more
core   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

open access: yesMolecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy